February 26, 2014
West is pleased to announce that it has received CE approval of the Intradermal (ID) Adapter. West received 510K clearance for the ID Adapter from the United States Food and Drug Administration in February 2013.
The ID adapter is designed to help improve the consistency and reliability of intradermal injections providing increased confidence for clinical trial results and better patient outcomes. The system will complement West’s portfolio of medical devices including reconstitution, safety and transfer systems.
Correctly administered ID injections can help conserve the supply of high-value vaccines and provide patients significant benefit through more reliable injection. The ID Adapter provides an alternative to the Mantoux method, the industry standard for intradermal injection since 1907. The Mantoux method requires extensive training and experience to perform correctly and consistently, whereas the ID Adapter enables this process to be carried out more easily, with less training and with greater reliability.
West conducted two clinical studies that verified the performance of the ID adapter. These studies confirmed a strong clinician preference for the ID adapter.
“We are delighted to offer our European customers a solution which can improve reliability and performance of intradermal injections and meet growing market demands in this area,” said Zach Marks, Marketing Director, Pharmaceutical Delivery Systems, West. Click here for more information on the ID Adapter technology.